Article

Amwell forecasts revenue between $195 million and $205 million for 2026, down from $249.3 million in 2025. The decline follows divestitures as the company refocuses on a single technology-enabled care platform.

While Amwell aims to break even on cash flow by Q4 2026, analysts note subscription revenue may also decline. The company narrowed its net loss to $95 million in 2025, though revenue decreased approximately 2% year-over-year, influenced by a reduced contract with the Defense Health Agency.